Stay updated with breaking news from Disease Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Robust and sustained efficacy in both adult PKD patients up to 30 months post-RP-L301; first pediatric patient results suggest efficacy similar to adult cohort with initial greater than five-point... | May 19, 2023
Positive CVN424 Phase 2 data for Parkinson’s disease to be presented Presentation of NETSseq platform’s ability to reveal novel targets to inform CNS drug...
The "Europe Gaucher's Disease Market and Competitive Landscape 2021" report has been added to ResearchAndMarkets.com's offering. The latest research provides comprehensive insights into Gaucher's
The "Global Fabry Disease Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. The latest research pro
The "Europe Addison's Disease Market and Competitive Landscape 2021" report has been added to ResearchAndMarkets.com's offering. Europe Addison's Disease Market and Competitive Landscape 2021, provides